IperionX Limited Sponsored ADR (NASDAQ:IPX) Receives Consensus Recommendation of “Moderate Buy” from Analysts

IperionX Limited Sponsored ADR (NASDAQ:IPX) has been given an average rating of “Moderate Buy” by the five analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $55.3333.

Several equities research analysts have recently weighed in on the company. Roth Mkm reissued a “buy” rating and set a $74.00 target price on shares of IperionX in a research report on Tuesday, January 20th. William Blair assumed coverage on shares of IperionX in a research report on Tuesday, January 13th. They set an “outperform” rating for the company. BTIG Research initiated coverage on shares of IperionX in a report on Friday. They issued a “buy” rating and a $40.00 target price for the company. B. Riley Financial dropped their target price on shares of IperionX from $58.00 to $52.00 and set a “buy” rating on the stock in a research report on Friday, March 13th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of IperionX in a research report on Thursday, January 22nd.

IperionX Stock Performance

Shares of NASDAQ:IPX opened at $21.98 on Friday. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03. IperionX has a fifty-two week low of $12.27 and a fifty-two week high of $61.45. The firm’s 50 day moving average price is $43.19 and its 200 day moving average price is $42.36.

IperionX (NASDAQ:IPX) last issued its earnings results on Friday, January 30th. The company reported ($0.50) EPS for the quarter. Equities research analysts predict that IperionX will post -0.08 EPS for the current fiscal year.

Institutional Trading of IperionX

Institutional investors and hedge funds have recently made changes to their positions in the company. Thomist Capital Management LP acquired a new stake in shares of IperionX in the 2nd quarter valued at about $59,384,000. Van ECK Associates Corp lifted its stake in IperionX by 61.0% in the fourth quarter. Van ECK Associates Corp now owns 1,337,343 shares of the company’s stock valued at $48,392,000 after buying an additional 506,612 shares during the last quarter. Jane Street Group LLC lifted its stake in IperionX by 62.5% in the fourth quarter. Jane Street Group LLC now owns 129,020 shares of the company’s stock valued at $4,669,000 after buying an additional 49,645 shares during the last quarter. Millennium Management LLC acquired a new stake in shares of IperionX in the fourth quarter valued at approximately $4,249,000. Finally, Osaic Holdings Inc. grew its position in shares of IperionX by 7.7% during the second quarter. Osaic Holdings Inc. now owns 70,325 shares of the company’s stock worth $2,215,000 after acquiring an additional 5,000 shares during the last quarter. 2.76% of the stock is owned by hedge funds and other institutional investors.

IperionX Company Profile

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.